Inactive Instrument

Meda AB Share Price

Equities

SE0000221723

Pharmaceuticals

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

2016	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
2016	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

Latest news about Meda AB

Meda : Mylan gets EU approval for Meda purchase, subject to conditions	20/16/20	RE
Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	15/16/15	RE
Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	02/16/02	RE
Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	09/16/09	RE
Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	11/16/11	RE
Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	15/16/15	RE
AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	14/14/14	RE
Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	12/14/12	RE
Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	12/14/12	RE
Banks vie for fees as Nordic deal scene ignites	15/14/15	RE
Actavis : Factbox - M&A frenzy transforming global pharma	06/14/06	RE
Actavis : M&A frenzy in healthcare sector	06/14/06	RE
Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	01/14/01	RE
AstraZeneca : Bayer offers animal health assets, cash for Merck's OTC unit -sources	30/14/30	RE
Allergan : Exclusive - Allergan eyes new takeover bid for Shire: sources	29/14/29	RE

Press releases Meda AB

Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	25/16/25	BU
Meda : Delisting of Meda Aktiebolag (publ)	08/16/08	BU
MEDA: Notice to noteholders regarding change of control	05/16/05	BU
Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	02/16/02	BU
Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	02/16/02	BU

More press releases

News in other languages on Meda AB

Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources	15/16/15
Cisco Systems : Wall Street ouvre en net recul	11/16/11
Meda : Mylan annonce le rachat du laboratoire suédois Meda	11/16/11
Mylan versucht es nach Perrigo-Pleite mit Brechstange: Meda-Gebot mit 92% Plus	11/16/11
Allergan préparerait une nouvelle offensive sur Shire	29/14/29

Managers and Directors - Meda AB

Managers	Title	Age	Since
Mårten Österlund FOU	Founder	67	01/99/01
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	62	01/05/01
Hans-Jürgen Tritschler SAM	Sales & Marketing	62	01/05/01

Members of the board	Title	Age	Since
Jacek Glinka CHM	Chairman	60	25/16/25
Colleen Ostrowski BRD	Director/Board Member	51	25/16/25
Caroline Rebecca Louise Dixon BRD	Director/Board Member	56	25/16/25

Company Profile

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals

+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019

Replicate our performance

fermer